IP Verse

Argentum Pharmaceuticals LLC et al. vs Cipla Limited et al.

The detailed information for PTAB case with proceeding number IPR2017-00807 filed by Argentum Pharmaceuticals LLC et al. against Cipla Limited et al. on Feb 2, 2017. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: IPR2017-00807
Filing Date: Feb 2, 2017
Petitioner: Argentum Pharmaceuticals LLC et al.
Respondent: Cipla Limited et al.
Status: Terminated-Settled
Respondent Application Number: 10518016
Respondent Tech Center: 1600
Respondent Patent Number: 8168620
Institution Decision Date: Aug 21, 2017
Termination Date: May 21, 2018

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
Granting Patent Owner's Motion to Expunge	May 29, 2018	PAPER	BOARD
Motion to Expunge	May 24, 2018	PAPER	PATENT OWNER
Termination Decision Document	May 21, 2018	PAPER	BOARD
Joint Request to File Settlement as BCI	May 17, 2018	PAPER	PATENT OWNER
2183 - Settlement Agreement (Confidential)	May 17, 2018	EXHIBIT	PATENT OWNER
Joint Motion to Terminate Proceedings	May 17, 2018	PAPER	PATENT OWNER
Petitioner's Objections to Patent Owner's Demonstrative Exhibit	May 14, 2018	PAPER	PETITIONER
Objections to Petitioner's Demonstratives	May 14, 2018	PAPER	PATENT OWNER
Exhibit List	May 11, 2018	PAPER	PATENT OWNER
2182 - Joint Stipulation to Limit Petition under 37 CFR 42.71	May 11, 2018	EXHIBIT	PATENT OWNER
Joint Motion to Limit Petition	May 11, 2018	PAPER	PATENT OWNER
Patent Owner's Reply to Opposition to Motion to Exclude	Apr 30, 2018	PAPER	PATENT OWNER
PETITIONER¿¿¿S REPLY TO PATENT OWNER¿¿¿S OPPOSITION TO PETITIONER¿¿¿S MOTION TO EXCLUDE	Apr 30, 2018	PAPER	PETITIONER
Conduct of the Proceeding	Apr 26, 2018	PAPER	BOARD
Updated Mandatory Notices	Apr 24, 2018	PAPER	PATENT OWNER
Patent Owner's Opposition to Motion to Exclude	Apr 24, 2018	PAPER	PATENT OWNER
Opposition to Patent Owner's Motion To Exclude Evidence	Apr 24, 2018	PAPER	PETITIONER
Ex. 1174	Apr 24, 2018	EXHIBIT	PETITIONER
Response to Patent Owner's Motion for Observations	Apr 24, 2018	PAPER	PETITIONER
Petitioner's Exhibit List of April 24, 2018	Apr 24, 2018	PAPER	PETITIONER
Ex. 1037	Apr 24, 2018	EXHIBIT	PETITIONER
Ex. 1043	Apr 24, 2018	EXHIBIT	PETITIONER
Ex. 1170	Apr 24, 2018	EXHIBIT	PETITIONER
Ex. 1175	Apr 24, 2018	EXHIBIT	PETITIONER
ORDER Oral Hearing 37 C.F.R. 42.70	Apr 10, 2018	PAPER	BOARD
Petitioner's Motion to Exclude Evidence	Apr 10, 2018	PAPER	PETITIONER
Ex. 1173 - email	Apr 10, 2018	EXHIBIT	PETITIONER
Petitioner's Exhibit List of April 10, 2018	Apr 10, 2018	PAPER	PETITIONER
Ex. 1172 - email	Apr 10, 2018	EXHIBIT	PETITIONER
Motion to Exclude	Apr 10, 2018	PAPER	PATENT OWNER
Motion for Observations on Cross Exam	Apr 10, 2018	PAPER	PATENT OWNER
Updated Exhibit List	Apr 10, 2018	PAPER	PATENT OWNER
Exhibit from Donovan's Second Deposition	Apr 10, 2018	EXHIBIT	PATENT OWNER
Second Donovan Deposition Transcript	Apr 10, 2018	EXHIBIT	PATENT OWNER
Second Schleimer Deposition Transcript	Apr 10, 2018	EXHIBIT	PATENT OWNER
Staines Deposition Transcript	Apr 10, 2018	EXHIBIT	PATENT OWNER
EX1171 - Staines Deposition Exhibit 1171	Apr 10, 2018	EXHIBIT	PATENT OWNER
Request for Oral Argument	Apr 9, 2018	PAPER	PATENT OWNER
Cipla Ltd.'s Corrected Request for Oral Argument	Apr 9, 2018	PAPER	PATENT OWNER
Request for Oral Argument	Apr 9, 2018	PAPER	PETITIONER
Stipulation Concerning Schedule	Apr 2, 2018	PAPER	PATENT OWNER
Staines Deposition Notice	Mar 29, 2018	PAPER	PATENT OWNER
2nd Donovan Deposition Notice	Mar 20, 2018	PAPER	PATENT OWNER
2nd Schleimer Deposition Notice	Mar 20, 2018	PAPER	PATENT OWNER
Patent Owner's Objections to Evidence As Of March 13, 2018	Mar 13, 2018	PAPER	PATENT OWNER
Dr. Accetta Patient Record (1998)	Mar 6, 2018	EXHIBIT	PETITIONER
Business Wire	Mar 6, 2018	EXHIBIT	PETITIONER
Center for Drug Evaluation and Research	Mar 6, 2018	EXHIBIT	PETITIONER
GlaxoSmithKline	Mar 6, 2018	EXHIBIT	PETITIONER
Fexofenadine	Mar 6, 2018	EXHIBIT	PETITIONER
US 6,417,206	Mar 6, 2018	EXHIBIT	PETITIONER
Meda AB	Mar 6, 2018	EXHIBIT	PETITIONER
Generic Astelin	Mar 6, 2018	EXHIBIT	PETITIONER
Cetirizine & Levocetirizine	Mar 6, 2018	EXHIBIT	PETITIONER
Loratadine & Desloratadine	Mar 6, 2018	EXHIBIT	PETITIONER
Durie	Mar 6, 2018	EXHIBIT	PETITIONER
Meda, "Annual Report 2015."	Mar 6, 2018	EXHIBIT	PETITIONER
Meda, "Annual Report 2014."	Mar 6, 2018	EXHIBIT	PETITIONER
Beclomethasone	Mar 6, 2018	EXHIBIT	PETITIONER
Brozek	Mar 6, 2018	EXHIBIT	PETITIONER
DiMasi	Mar 6, 2018	EXHIBIT	PETITIONER
Summary Application Review: Application Number 22-203	Mar 6, 2018	EXHIBIT	PETITIONER
Meda, "Annual Report 2013."	Mar 6, 2018	EXHIBIT	PETITIONER
Prescription Drug Pricing in the Private Sector	Mar 6, 2018	EXHIBIT	PETITIONER
Sur	Mar 6, 2018	EXHIBIT	PETITIONER
2010 Top 200 Branded Drugs by Retail Dollars	Mar 6, 2018	EXHIBIT	PETITIONER
Top 200 Brand-Name Drugs by Retail Dollars in 2005	Mar 6, 2018	EXHIBIT	PETITIONER
Grabowski	Mar 6, 2018	EXHIBIT	PETITIONER
Meda, "Annual Report 2012."	Mar 6, 2018	EXHIBIT	PETITIONER
Meda, "Annual Report 2009."	Mar 6, 2018	EXHIBIT	PETITIONER
2010 top 200 Generic Drugs by Total Prescriptions	Mar 6, 2018	EXHIBIT	PETITIONER
Carrier	Mar 6, 2018	EXHIBIT	PETITIONER
Herper	Mar 6, 2018	EXHIBIT	PETITIONER
Prescription Drug Pricing in the Private Sector	Mar 6, 2018	EXHIBIT	PETITIONER
Scherer	Mar 6, 2018	EXHIBIT	PETITIONER
Danzon	Mar 6, 2018	EXHIBIT	PETITIONER
Concepts in Managed Care Pharmacy	Mar 6, 2018	EXHIBIT	PETITIONER
Promotional Spending for Prescription Drugs	Mar 6, 2018	EXHIBIT	PETITIONER
Scherer	Mar 6, 2018	EXHIBIT	PETITIONER
Yi	Mar 6, 2018	EXHIBIT	PETITIONER
Patwardhan	Mar 6, 2018	EXHIBIT	PETITIONER
Fugh-Berman	Mar 6, 2018	EXHIBIT	PETITIONER
Elliott	Mar 6, 2018	EXHIBIT	PETITIONER
Voet	Mar 6, 2018	EXHIBIT	PETITIONER
Shadowen	Mar 6, 2018	EXHIBIT	PETITIONER
Dymista NDA Approval	Mar 6, 2018	EXHIBIT	PETITIONER
How Increased Competition from Generic Drugs has Affected Prices and Returns in the Pharmaceutical Industry	Mar 6, 2018	EXHIBIT	PETITIONER
Danzon - Health Insurance	Mar 6, 2018	EXHIBIT	PETITIONER
ABA Section of Antitrust Law	Mar 6, 2018	EXHIBIT	PETITIONER
Lu	Mar 6, 2018	EXHIBIT	PETITIONER
Allan	Mar 6, 2018	EXHIBIT	PETITIONER
DocGuide.com	Mar 6, 2018	EXHIBIT	PETITIONER
Traimcinolone	Mar 6, 2018	EXHIBIT	PETITIONER
NDC Director - Ticanase	Mar 6, 2018	EXHIBIT	PETITIONER
Shrank	Mar 6, 2018	EXHIBIT	PETITIONER
Shelley	Mar 6, 2018	EXHIBIT	PETITIONER
Apotex Corp.	Mar 6, 2018	EXHIBIT	PETITIONER
Perrigo	Mar 6, 2018	EXHIBIT	PETITIONER
Apotex Launches First Generic Version of Merck's Nasonex	Mar 6, 2018	EXHIBIT	PETITIONER
Vaidyanathan	Mar 6, 2018	EXHIBIT	PETITIONER
Flunisolide	Mar 6, 2018	EXHIBIT	PETITIONER
Claritin-D Drug Approval	Mar 6, 2018	EXHIBIT	PETITIONER
Nasalide Drug Approval	Mar 6, 2018	EXHIBIT	PETITIONER
Fluticasone Propionate	Mar 6, 2018	EXHIBIT	PETITIONER
Olopatadine	Mar 6, 2018	EXHIBIT	PETITIONER
Budesonide	Mar 6, 2018	EXHIBIT	PETITIONER
Mometasone	Mar 6, 2018	EXHIBIT	PETITIONER
2010 Top 200 Branded Drugs by Total Prescriptions	Mar 6, 2018	EXHIBIT	PETITIONER
McDuff	Mar 6, 2018	EXHIBIT	PETITIONER
Tidwell	Mar 6, 2018	EXHIBIT	PETITIONER
Ayalew	Mar 6, 2018	EXHIBIT	PETITIONER
Gottlieb	Mar 6, 2018	EXHIBIT	PETITIONER
Apotex - Pharmacy Times	Mar 6, 2018	EXHIBIT	PETITIONER
Morton	Mar 6, 2018	EXHIBIT	PETITIONER
Bhadoria	Mar 6, 2018	EXHIBIT	PETITIONER
Salunke	Mar 6, 2018	EXHIBIT	PETITIONER
Gilbert	Mar 6, 2018	EXHIBIT	PETITIONER
Mahr	Mar 6, 2018	EXHIBIT	PETITIONER
Parliament of India Report	Mar 6, 2018	EXHIBIT	PETITIONER
Kataria	Mar 6, 2018	EXHIBIT	PETITIONER
Bhargava	Mar 6, 2018	EXHIBIT	PETITIONER
Pfizer India	Mar 6, 2018	EXHIBIT	PETITIONER
Beconase AQ	Mar 6, 2018	EXHIBIT	PETITIONER
Weigmann	Mar 6, 2018	EXHIBIT	PETITIONER
Morton	Mar 6, 2018	EXHIBIT	PETITIONER
Authorized Generic Drugs: Short-Term Effects and Long-Term Impact	Mar 6, 2018	EXHIBIT	PETITIONER
Canadian Generic Drug Sector Study	Mar 6, 2018	EXHIBIT	PETITIONER
India Pharma Inc.	Mar 6, 2018	EXHIBIT	PETITIONER
Lanjouw	Mar 6, 2018	EXHIBIT	PETITIONER
Curriculum Vitae of John C. Staines, Jr.	Mar 6, 2018	EXHIBIT	PETITIONER
Deposition Transcript of Dr. Alexander Dominic D¿¿¿Addio	Mar 6, 2018	EXHIBIT	PETITIONER
Deposition Transcript of Dr. Warner W. Carr	Mar 6, 2018	EXHIBIT	PETITIONER
Deposition Transcript of Dr. Hugh David Charles Smyth	Mar 6, 2018	EXHIBIT	PETITIONER
Dell and Colliopoulos	Mar 6, 2018	EXHIBIT	PETITIONER
GREIFF	Mar 6, 2018	EXHIBIT	PETITIONER
Han	Mar 6, 2018	EXHIBIT	PETITIONER
Corren	Mar 6, 2018	EXHIBIT	PETITIONER
LaForce	Mar 6, 2018	EXHIBIT	PETITIONER
Updated Curriculum Vitae of Dr. Robert Schleimer	Mar 6, 2018	EXHIBIT	PETITIONER
Nairn	Mar 6, 2018	EXHIBIT	PETITIONER
Rhinolast Nasal Spray	Mar 6, 2018	EXHIBIT	PETITIONER
Schmidt	Mar 6, 2018	EXHIBIT	PETITIONER
U.S. Patent No. 3,636,200	Mar 6, 2018	EXHIBIT	PETITIONER
U.S. Patent No. 5,196,436	Mar 6, 2018	EXHIBIT	PETITIONER
U.S. Patent No. 5,658,919	Mar 6, 2018	EXHIBIT	PETITIONER
U.S. Patent No. 6,565,832	Mar 6, 2018	EXHIBIT	PETITIONER
PCT Publication No. WO01/28563	Mar 6, 2018	EXHIBIT	PETITIONER
Patent Assignment	Mar 6, 2018	EXHIBIT	PETITIONER
E-mail: February 20, 2018 to March 5, 2018	Mar 6, 2018	EXHIBIT	PETITIONER
Berger	Mar 6, 2018	EXHIBIT	PETITIONER
Berger	Mar 6, 2018	EXHIBIT	PETITIONER
McNeely	Mar 6, 2018	EXHIBIT	PETITIONER
U.S. Patent No. 8,933,060	Mar 6, 2018	EXHIBIT	PETITIONER
U.S. Patent No. 8,304,405	Mar 6, 2018	EXHIBIT	PETITIONER
Kublik	Mar 6, 2018	EXHIBIT	PETITIONER
Declaration of John C. Staines, Jr.	Mar 6, 2018	EXHIBIT	PETITIONER
Second Declaration of Dr. Robert Schleimer	Mar 6, 2018	EXHIBIT	PETITIONER
EXPUNGED	Mar 6, 2018	EXHIBIT	PETITIONER
Petitioner's Motion to Seal	Mar 6, 2018	PAPER	PETITIONER
PETITIONER REPLY TO PATENT OWNER RESPONSE	Mar 6, 2018	PAPER	PETITIONER
Second Declaration of Dr. Maureen Donovan (redacted version)	Mar 6, 2018	EXHIBIT	PETITIONER
Petitioner's Exhibit List of March 6, 2018	Mar 6, 2018	PAPER	PETITIONER
Notice of Deposition - D'Addio	Feb 14, 2018	PAPER	PETITIONER
Notice of Deposition - Carr	Feb 5, 2018	PAPER	PETITIONER
Stipulation Concerning Schedule	Feb 2, 2018	PAPER	PETITIONER
Notice of Deposition - Smyth	Jan 29, 2018	PAPER	PETITIONER
Petitioner's Updated Mandatory Notice	Jan 29, 2018	PAPER	PETITIONER
USPN 6,599,914	Nov 20, 2017	EXHIBIT	PATENT OWNER
US Utility 09_841,506	Nov 20, 2017	EXHIBIT	PATENT OWNER
Second Carr Declaration	Nov 20, 2017	EXHIBIT	PATENT OWNER
Second D'Addio Declaration	Nov 20, 2017	EXHIBIT	PATENT OWNER
Second Jarosz Declaration	Nov 20, 2017	EXHIBIT	PATENT OWNER
Handbook of Pharmaceutical Excipients 2000	Nov 20, 2017	EXHIBIT	PATENT OWNER
Hayashi 1999	Nov 20, 2017	EXHIBIT	PATENT OWNER
Schleimer Deposition Transcript	Nov 20, 2017	EXHIBIT	PATENT OWNER
Donovan Deposition Transcript	Nov 20, 2017	EXHIBIT	PATENT OWNER
Amended Default Protective Order	Nov 20, 2017	EXHIBIT	PATENT OWNER
Barnes 2001	Nov 20, 2017	EXHIBIT	PATENT OWNER
Andy 2002	Nov 20, 2017	EXHIBIT	PATENT OWNER
MMIT Dymista Formulary Information	Nov 20, 2017	EXHIBIT	PATENT OWNER
Sept. 7, 2007 FDA Letter	Nov 20, 2017	EXHIBIT	PATENT OWNER
May 19. 2008 FDA Letter	Nov 20, 2017	EXHIBIT	PATENT OWNER
Sherman 1951	Nov 20, 2017	EXHIBIT	PATENT OWNER
Updated Jarosz CV	Nov 20, 2017	EXHIBIT	PATENT OWNER
Clarinex Label - 2001	Nov 20, 2017	EXHIBIT	PATENT OWNER
Storms 1997	Nov 20, 2017	EXHIBIT	PATENT OWNER
Cipla Duonase Manufacturing Guide - PUBLIC	Nov 20, 2017	EXHIBIT	PATENT OWNER
Cipla Duonase Manufacturing Guide - PUBLIC	Nov 20, 2017	EXHIBIT	PATENT OWNER
Dymista Investigation Report	Nov 20, 2017	EXHIBIT	PATENT OWNER
Dymista NDA Excerpt - PUBLIC	Nov 20, 2017	EXHIBIT	PATENT OWNER
Cipla Duonase Stability Testing Form - PUBLIC	Nov 20, 2017	EXHIBIT	PATENT OWNER
Second Smyth Declaration - PUBLIC	Nov 20, 2017	EXHIBIT	PATENT OWNER
EXPUNGED	Nov 20, 2017	EXHIBIT	PATENT OWNER
EXPUNGED	Nov 20, 2017	EXHIBIT	PATENT OWNER
EXPUNGED	Nov 20, 2017	EXHIBIT	PATENT OWNER
EXPUNGED	Nov 20, 2017	EXHIBIT	PATENT OWNER
EXPUNGED	Nov 20, 2017	EXHIBIT	PATENT OWNER
EXPUNGED	Nov 20, 2017	EXHIBIT	PATENT OWNER
Patent Owner Response	Nov 20, 2017	PAPER	PATENT OWNER
Exhibit List	Nov 20, 2017	PAPER	PATENT OWNER
Motion to Seal	Nov 20, 2017	PAPER	PATENT OWNER
Decision - Denying Patent Owner's Request for Rehearing	Oct 31, 2017	PAPER	BOARD
Denying Petitioners Request for Rehearing 37 C.F.R. sec 42.71(d)	Oct 30, 2017	PAPER	BOARD
Notice of Deposition of Robert P. Schleimer, Ph.D.	Oct 5, 2017	PAPER	PATENT OWNER
Notice of Deposition of Maureen D. Donovan, Ph.D.	Oct 5, 2017	PAPER	PATENT OWNER
Petitioner's Request for Rehearing	Sep 5, 2017	PAPER	PETITIONER
Cipla Limited's Objections to Evidence	Sep 5, 2017	PAPER	PATENT OWNER
Cipla Limited's Request for Rehearing	Sep 5, 2017	PAPER	PATENT OWNER
Petitioner's Objections to Evidence	Sep 5, 2017	PAPER	PETITIONER
Trial Instituted Document	Aug 21, 2017	PAPER	BOARD
Scheduling Order	Aug 21, 2017	PAPER	BOARD
Order Granting Patent Owner Motion for Pro Hac Vice Admission of Uma N. Everett	Jun 8, 2017	PAPER	BOARD
Patent Owner's Updated Mandatory Notices	Jun 2, 2017	PAPER	PATENT OWNER
Complaint for Patent Infringement, December 2, 2014, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-UNA (D. Del.)	May 30, 2017	EXHIBIT	PATENT OWNER
Expert Report of Robert P. Schleimer, Ph.D., August 19, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.)	May 30, 2017	EXHIBIT	PATENT OWNER
Expert Rebuttal Report of Robert P. Schleimer, Ph.D., July 29, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.)	May 30, 2017	EXHIBIT	PATENT OWNER
Expert Reply Report of Maureen D. Donovan, Ph.D., August 19, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.)	May 30, 2017	EXHIBIT	PATENT OWNER
Bench Trial Transcript, Volume A, December 13, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.)	May 30, 2017	EXHIBIT	PATENT OWNER
Complaint for Patent Infringement, September 9, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Perrigo UK Finko Limited Partnership, Perrigo Company and Perrigo Pharmaceuticals Co., Case No. 1:16-cv-00794-LPS (D. Del.)	May 30, 2017	EXHIBIT	PATENT OWNER
Expert Reply Report of Robert P. Schleimer, Ph.D., August 19, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.)	May 30, 2017	EXHIBIT	PATENT OWNER
Dr. Maureen Donovan Deposition transcript, October 7, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.)	May 30, 2017	EXHIBIT	PATENT OWNER
Expert Report of Maureen D. Donovan, Ph.D., June 30, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.)	May 30, 2017	EXHIBIT	PATENT OWNER
Bench Trial Transcript, Volume B, December 14, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.)	May 30, 2017	EXHIBIT	PATENT OWNER
Bench Trial Transcript, Volume C, December 15, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.)	May 30, 2017	EXHIBIT	PATENT OWNER
Defendants' Opening Post-Trial Brief, January 24, 2017, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.) (D.I. 158)	May 30, 2017	EXHIBIT	PATENT OWNER
Gennaro, A. R. Remington's Pharmaceutical Sciences (17th ed., 1985), Ch. 80: 1455-1477; Ch. 82: 1478-1491; Ch. 84:1492-1517	May 30, 2017	EXHIBIT	PATENT OWNER
Avomeen Analytical Services Report, June 30, 2016 (PTX0129)	May 30, 2017	EXHIBIT	PATENT OWNER
Expert Report of Dr. Govindarajan and Corresponding Documents (PTX1664)	May 30, 2017	EXHIBIT	PATENT OWNER
Physicians' Desk Reference, 54th ed., pp. 1343-1344, 2404-2406, 2781-2783 (2000)	May 30, 2017	EXHIBIT	PATENT OWNER
British Pharmaceutical Codex 1973 (PTX0193)	May 30, 2017	EXHIBIT	PATENT OWNER
Bench Trial Transcript, Volume D, December 16, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.)	May 30, 2017	EXHIBIT	PATENT OWNER
Plaintiffs' Proposed Findings of Fact, January 10, 2017, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.) (D.I. 155)	May 30, 2017	EXHIBIT	PATENT OWNER
Defendants' Proposed Finding of Facts, January 10, 2017, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.) (D.I. 156)	May 30, 2017	EXHIBIT	PATENT OWNER
Dr. Robert Schleimer Deposition transcript, September 29, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.)	May 30, 2017	EXHIBIT	PATENT OWNER
Accolate Approval Letter and Label, Application Number 20-547/S011, Zeneca Pharmaceuticals	May 30, 2017	EXHIBIT	PATENT OWNER
Expert Report of Dr. Matthew J. Herpin and Corresponding Documents (PTX1663)	May 30, 2017	EXHIBIT	PATENT OWNER
Duonase Imitator Product Labels (PTX0026)	May 30, 2017	EXHIBIT	PATENT OWNER
Allegra-D Approval Letter, Application Number 20786, Approved December 24, 1997, (PTX0126)	May 30, 2017	EXHIBIT	PATENT OWNER
Riordan, John. An Introduction to Combinatorial Analysis (1958), Ch. 1: 1-18	May 30, 2017	EXHIBIT	PATENT OWNER
Zyrtec-D FDA Label, Approved August 10, 2001	May 30, 2017	EXHIBIT	PATENT OWNER
Argentum Pharmaceuticals Website, accessed May 17, 2017	May 30, 2017	EXHIBIT	PATENT OWNER
Khan 2000 (PTX0194)	May 30, 2017	EXHIBIT	PATENT OWNER
Flonase¿¿ Label 1998 (PTX0059)	May 30, 2017	EXHIBIT	PATENT OWNER
Howarth 2000 (PTX0337)	May 30, 2017	EXHIBIT	PATENT OWNER
Nielsen 2001 (PTX0338)	May 30, 2017	EXHIBIT	PATENT OWNER
Shenfield 1986 (DTX-048)	May 30, 2017	EXHIBIT	PATENT OWNER
Michael 2001 (PTX0179)	May 30, 2017	EXHIBIT	PATENT OWNER
Leung 2012 (PTX0029)	May 30, 2017	EXHIBIT	PATENT OWNER
Global Data September 2015 (PTX0397)	May 30, 2017	EXHIBIT	PATENT OWNER
Astelin¿¿ Day Life CyclePlan November 2002 (PTX1005)	May 30, 2017	EXHIBIT	PATENT OWNER
Astelin¿¿ Nasal Spray Life Cycle Management Projects (Preliminary Plan) (PTX1006)	May 30, 2017	EXHIBIT	PATENT OWNER
2006.03.21 Email and attachment from Kalidas Kale to Alex D'Addio re: Astelin ¿¿¿ Flonase Combination Product Feasibility Assessment Plan (PTX0151)	May 30, 2017	EXHIBIT	PATENT OWNER
U.S. Patent No. 8,071,073	May 30, 2017	EXHIBIT	PATENT OWNER
IMS data for U.S. allergic rhinitis products, 01.2012-04.2016 (PTX0929)	May 30, 2017	EXHIBIT	PATENT OWNER
2011.11.02 Email and attachment from Ashwini Dumaswala to Bryan Roecklein re: 2012 Dymista¿¿ Strategic Plan (PTX1118)	May 30, 2017	EXHIBIT	PATENT OWNER
All Products - Apotex Products: United States, accessed June 22, 2016	May 30, 2017	EXHIBIT	PATENT OWNER
Drug Approval Package: Dymista¿¿, Approved May 1, 2012 (PTX0392)	May 30, 2017	EXHIBIT	PATENT OWNER
Hampel 2010 (PTX0230)	May 30, 2017	EXHIBIT	PATENT OWNER
Weiler 1997 (PTX0329)	May 30, 2017	EXHIBIT	PATENT OWNER
Blaiss 2001 (PTX0058)	May 30, 2017	EXHIBIT	PATENT OWNER
DataMonitor, July 2010 (PTX0396)	May 30, 2017	EXHIBIT	PATENT OWNER
2006 Cipla-Meda License Agreement with Quality Agreement (PTX1016)	May 30, 2017	EXHIBIT	PATENT OWNER
2011 First Amendment to Cipla-Meda Agreement (PTX0282)	May 30, 2017	EXHIBIT	PATENT OWNER
MedPointe Product & Process Development Program Priorities and Issues September 2002 (PTX0143)	May 30, 2017	EXHIBIT	PATENT OWNER
2006.02.06 Email from Paul Edick to Dennis Fuge re: Pfeiffer Bi Dose Nasal Spray System (PTX0149)	May 30, 2017	EXHIBIT	PATENT OWNER
U.S. Patent No. 8,518,919	May 30, 2017	EXHIBIT	PATENT OWNER
MedPointe Laboratory Notebook No. 1044 - Excerpts (PTX0142)	May 30, 2017	EXHIBIT	PATENT OWNER
Dymista¿¿ Prescribing Information 2015 (PTX0024)	May 30, 2017	EXHIBIT	PATENT OWNER
Duonase Nasal Spray ¿¿¿ Prescribing Information (PTX0134)	May 30, 2017	EXHIBIT	PATENT OWNER
Cipla Website,accessed June 28, 2016 (PTX0380)	May 30, 2017	EXHIBIT	PATENT OWNER
IMS data for Duonase competitor products, 2005-2016 (PTX0816)	May 30, 2017	EXHIBIT	PATENT OWNER
Meda AB Interim Report Jan.-Sept. 2012 (PTX0393)	May 30, 2017	EXHIBIT	PATENT OWNER
Cipla Website, accessed June 28, 2016 (PTX0379)	May 30, 2017	EXHIBIT	PATENT OWNER
Dymista¿¿ briefing document (PTX1654)	May 30, 2017	EXHIBIT	PATENT OWNER
2014.11.14 Email and attachment from Stuart Loeschto Betsy Orrison re: Dymista¿¿ US Marketing Plan 2015 (PTX0271)	May 30, 2017	EXHIBIT	PATENT OWNER
Dymista¿¿ Competitor Benchmarking Presentation 2012 (PTX0926)	May 30, 2017	EXHIBIT	PATENT OWNER
2011.11.02 Email and attachment from Ashwini Dumaswala to Bryan Roecklein re: 2012 Dymista¿¿ Strategy Plan (PTX0267)	May 30, 2017	EXHIBIT	PATENT OWNER
MEDA Presentation (2001) (PTX0871)	May 30, 2017	EXHIBIT	PATENT OWNER
Transmittal of advertisements and promotional labeling to the U.S. Food and Drug Administration for Dymista¿¿, June 16, 2015 (PTX0916)	May 30, 2017	EXHIBIT	PATENT OWNER
Transmittal of advertisements and promotional labeling to the U.S. Food and Drug Administration for Dymista¿¿, November 26, 2012 (PTX0917)	May 30, 2017	EXHIBIT	PATENT OWNER
Transmittal of advertisements and promotional labeling to the U.S. Food and Drug Administration for Dymista¿¿, June 29, 2015 (PTX0915)	May 30, 2017	EXHIBIT	PATENT OWNER
Physicians' Desk Reference, 54th ed., pp. 2783- 2786 (2000)	May 30, 2017	EXHIBIT	PATENT OWNER
Meda ¿¿¿ 2016 Dymista¿¿ Brand Plan (PTX0406)	May 30, 2017	EXHIBIT	PATENT OWNER
fda.gov,"Prescription to Over-the-Counter (OTC) Switch List," accessed June 28, 2016 (PTX0407)	May 30, 2017	EXHIBIT	PATENT OWNER
Johnson & Johnson Press Release,"RHINOCORT¿¿ Allergy Spray Now Available Over The Counter Nationally," dated February 8, 2016	May 30, 2017	EXHIBIT	PATENT OWNER
FDA.gov, "First-Time Generic Drug Approvals - March 2016," (accessed June 28, 2016) (PTX0424)	May 30, 2017	EXHIBIT	PATENT OWNER
Renavatio Presentation & Meda Presentation (PTX0426)	May 30, 2017	EXHIBIT	PATENT OWNER
Transmittal of advertisements and promotional labeling to the U.S. Food and Drug Administration for Dymista¿¿, June 17, 2015 (PTX0914)	May 30, 2017	EXHIBIT	PATENT OWNER
Cipla Duonase Marketing Presentation (PTX0315)	May 30, 2017	EXHIBIT	PATENT OWNER
Meda/Cipla Powerpoint ¿¿¿ Complete Picture (PTX0412)	May 30, 2017	EXHIBIT	PATENT OWNER
healthcare.utah, "The Difference Between AR and Sinusitis," accessed June 28, 2016 (PTX0429)	May 30, 2017	EXHIBIT	PATENT OWNER
Bousquet "Allergic Rhinitis," accessed June 28, 2016 (PTX0431)	May 30, 2017	EXHIBIT	PATENT OWNER
Family Allergy & Asthma Care of Montana Website, accessed June 28, 2016 (PTX0430)	May 30, 2017	EXHIBIT	PATENT OWNER
Samuelson and Nordhaus 2010 (PTX0415)	May 30, 2017	EXHIBIT	PATENT OWNER
Dymista¿¿ Marketing Plan 2016 (PTX0438)	May 30, 2017	EXHIBIT	PATENT OWNER
Dymista¿¿ Formulary Coverage Powerpoint 2014 (PTX0892)	May 30, 2017	EXHIBIT	PATENT OWNER
Meda Memorandum re: CVS Caremark Formulary Decisions 2015 (PTX0447)	May 30, 2017	EXHIBIT	PATENT OWNER
Bagwell 2007 (PTX0432)	May 30, 2017	EXHIBIT	PATENT OWNER
Ching 2010 (PTX0433)	May 30, 2017	EXHIBIT	PATENT OWNER
Berndt 2001 (PTX0434)	May 30, 2017	EXHIBIT	PATENT OWNER
Bloomberg Website, accessed May 19, 2017	May 30, 2017	EXHIBIT	PATENT OWNER
The United States Pharmacopeia 1999 (PTX0188)	May 30, 2017	EXHIBIT	PATENT OWNER
Shin Etsu Pharmacoat USP Hypromellose Brochure (2005) (PTX0186)	May 30, 2017	EXHIBIT	PATENT OWNER
Gennaro 2000 (PTX0184)	May 30, 2017	EXHIBIT	PATENT OWNER
Kibbe 2000 (PTX0198)	May 30, 2017	EXHIBIT	PATENT OWNER
Michael 2000 (PTX0180)	May 30, 2017	EXHIBIT	PATENT OWNER
Newsroom Website accessed May 19, 2017	May 30, 2017	EXHIBIT	PATENT OWNER
Apotex Press Release "Apotex Launches First Generic Version of Merck's Nasonex¿¿," dated March 24, 2016	May 30, 2017	EXHIBIT	PATENT OWNER
Lieberman 1996 (PTX0177)	May 30, 2017	EXHIBIT	PATENT OWNER
Meda Highlights of Prescribing Information 2015 (PTX0154)	May 30, 2017	EXHIBIT	PATENT OWNER
2003.11.11 Email and attachment from Mary Lehr to Gul Balwani (PTX0255)	May 30, 2017	EXHIBIT	PATENT OWNER
IMS data for Indian allergic rhinitis nasal sprays products, March 2013 ¿¿¿ March 2017	May 30, 2017	EXHIBIT	PATENT OWNER
IMS data for Duonase competitor products, 2005-2017	May 30, 2017	EXHIBIT	PATENT OWNER
"What is a Tiered Formulary and What Does it Mean for Me?," accessed May 26, 2017	May 30, 2017	EXHIBIT	PATENT OWNER
Talbot 1997	May 30, 2017	EXHIBIT	PATENT OWNER
DataMonitor ¿¿¿ "Commercial and Stakeholder Perspectives: Allergic Rhinitis," September 2004 (PTX0098)	May 30, 2017	EXHIBIT	PATENT OWNER
Publicly Filed Proposed Joint Pretrial Order, November 10, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D.I.137) (Redactions in Original)	May 30, 2017	EXHIBIT	PATENT OWNER
Allen 1998 (PTX0167)	May 30, 2017	EXHIBIT	PATENT OWNER
Lieberman 1996 (PTX0192)	May 30, 2017	EXHIBIT	PATENT OWNER
MedPointe Product & Process Development, Program Priorities and Issues - November 18, 2002, "Commercial Product Technical Support" (PTX0144)	May 30, 2017	EXHIBIT	PATENT OWNER
2006.02.06 Email from Richard Spivey to Alex D'Addio re: Pfeiffer Bi Dose Nasal Spray System (PTX0150)	May 30, 2017	EXHIBIT	PATENT OWNER
IMS data for Indian allergic rhinitis nasal spray products, December 2010-December 2014 (PTX0823)	May 30, 2017	EXHIBIT	PATENT OWNER
2017.03.21 Email from Mike Houston to Adam LaRock re IPR2017-00807	May 30, 2017	EXHIBIT	PATENT OWNER
Center for Drug Evaluation and Research 2000 (PTX0025)	May 30, 2017	EXHIBIT	PATENT OWNER
webmd.com, "FDA Oks Generic Version of Flonase," accessed May 26, 2017	May 30, 2017	EXHIBIT	PATENT OWNER
IMS data for U.S. allergic rhinitis products, May 2011 - April 2017	May 30, 2017	EXHIBIT	PATENT OWNER
Bousquet 2001 (PTX0326)	May 30, 2017	EXHIBIT	PATENT OWNER
Memorandum Opinion, May 12, 2016, Meda Pharmaceuticals Inc. and Cipla Ltd., v. Apotex Inc. and Apotex Corp., Case No. 1:14-cv-01453-LPS (D. Del.) (D.I. 114)	May 30, 2017	EXHIBIT	PATENT OWNER
Wade and Weller 1994	May 30, 2017	EXHIBIT	PATENT OWNER
Warner Carr, M.D. Curriculum Vitae	May 30, 2017	EXHIBIT	PATENT OWNER
Alexander Dominic D'Addio, Ph.D. Declaration	May 30, 2017	EXHIBIT	PATENT OWNER
Alexander Dominic D'Addio, Ph.D. Curriculum Vitae	May 30, 2017	EXHIBIT	PATENT OWNER
Hugh David Charles Smyth, Ph.D. Declaration	May 30, 2017	EXHIBIT	PATENT OWNER
Hugh David Charles Smyth, Ph.D. Curriculum Vitae	May 30, 2017	EXHIBIT	PATENT OWNER
Cipla Ltd.'s Exhibit List	May 30, 2017	PAPER	PATENT OWNER
Affidavit in Support of Motion for Pro Hac Vice Admission of Uma N. Everett	May 30, 2017	EXHIBIT	PATENT OWNER
Cipla Ltd.'s Patent Owner Preliminary Response	May 30, 2017	PAPER	PATENT OWNER
Patent Owner Cipla Limited's Motion for Pro Hac Vice Admission of Uma N. Everett Under 37 CFR ¿¿ 42.10(c)	May 30, 2017	PAPER	PATENT OWNER
Warner Carr, M.D. Declaration	May 30, 2017	EXHIBIT	PATENT OWNER
John C. Jarosz Declaration	May 30, 2017	EXHIBIT	PATENT OWNER
John C. Jarosz Curriculum Vitae	May 30, 2017	EXHIBIT	PATENT OWNER
Declaration of Adam C. LaRock	May 30, 2017	EXHIBIT	PATENT OWNER
Notice of Accord Filing Date	Feb 28, 2017	PAPER	BOARD
Cipla Limited's Power of Attorney	Feb 23, 2017	PAPER	PATENT OWNER
Cipla Limited's Mandatory Notices	Feb 23, 2017	PAPER	PATENT OWNER
Petitioner Power of Attorney	Feb 2, 2017	PAPER	PETITIONER
U.S. Patent No. 8,168,620	Feb 2, 2017	EXHIBIT	PETITIONER
Prosecution History of U.S. Patent No. 8,168,620 (Part 1 of 2)	Feb 2, 2017	EXHIBIT	PETITIONER
European Patent Application No. 0780127	Feb 2, 2017	EXHIBIT	PETITIONER
Prosecution History of U.S. Patent No. 8,168,620 (Part 2 of 2)	Feb 2, 2017	EXHIBIT	PETITIONER
Meda Pharms. Inc. v. Apotex Inc.	Feb 2, 2017	EXHIBIT	PETITIONER
UK Patent Application GB 0213739.6	Feb 2, 2017	EXHIBIT	PETITIONER
U.S. Patent No. 5,164,194	Feb 2, 2017	EXHIBIT	PETITIONER
Astelin Label	Feb 2, 2017	EXHIBIT	PETITIONER
U.S. Patent No. 4,335,121	Feb 2, 2017	EXHIBIT	PETITIONER
Flonase Label	Feb 2, 2017	EXHIBIT	PETITIONER
British Pharmaceutical Codex	Feb 2, 2017	EXHIBIT	PETITIONER
U.S. Patent Publication No. 20040136918	Feb 2, 2017	EXHIBIT	PETITIONER
Falser, N., et al.	Feb 2, 2017	EXHIBIT	PETITIONER
Johnson, M.	Feb 2, 2017	EXHIBIT	PETITIONER
Dykewicz, Mark S., et al.	Feb 2, 2017	EXHIBIT	PETITIONER
Stoloff, R., et al.	Feb 2, 2017	EXHIBIT	PETITIONER
Berger, W. E. et al.	Feb 2, 2017	EXHIBIT	PETITIONER
Bousquet et al.	Feb 2, 2017	EXHIBIT	PETITIONER
Advair Diskus Prescribing Information	Feb 2, 2017	EXHIBIT	PETITIONER
Juniper, E	Feb 2, 2017	EXHIBIT	PETITIONER
PCT Publication No. WO 98/48839	Feb 2, 2017	EXHIBIT	PETITIONER
Kusters, S., et al.	Feb 2, 2017	EXHIBIT	PETITIONER
Stellato, C., et al.	Feb 2, 2017	EXHIBIT	PETITIONER
Cauwenberge, P. et al.	Feb 2, 2017	EXHIBIT	PETITIONER
Spector, S.	Feb 2, 2017	EXHIBIT	PETITIONER
Markham, A., et al.	Feb 2, 2017	EXHIBIT	PETITIONER
Ansel, et al.	Feb 2, 2017	EXHIBIT	PETITIONER
Wade & Weller	Feb 2, 2017	EXHIBIT	PETITIONER
Ratner, P., et al. (1998)	Feb 2, 2017	EXHIBIT	PETITIONER
Simpson, R.	Feb 2, 2017	EXHIBIT	PETITIONER
Galant, S. and Wilkinson, R.	Feb 2, 2017	EXHIBIT	PETITIONER
Schleimer, R.	Feb 2, 2017	EXHIBIT	PETITIONER
IMITREX Prescribing Information	Feb 2, 2017	EXHIBIT	PETITIONER
NASACORT AQ Prescribing Information	Feb 2, 2017	EXHIBIT	PETITIONER
Drouin, M., et al.	Feb 2, 2017	EXHIBIT	PETITIONER
Brooks, C. et al.	Feb 2, 2017	EXHIBIT	PETITIONER
Juniper, E F	Feb 2, 2017	EXHIBIT	PETITIONER
Benincasa, C. & Lloyd, R.S.	Feb 2, 2017	EXHIBIT	PETITIONER
Ratner, Paul H., et al. (2008)	Feb 2, 2017	EXHIBIT	PETITIONER
Rabago, David, et al.	Feb 2, 2017	EXHIBIT	PETITIONER
Budavari, S., et al.	Feb 2, 2017	EXHIBIT	PETITIONER
Ratner (1994)	Feb 2, 2017	EXHIBIT	PETITIONER
Curriculum Vitae of Dr. Robert Schleimer	Feb 2, 2017	EXHIBIT	PETITIONER
Patent Certification for U.S. Patent No. 5,164,194 - Astelin Nasal Spray (2000)	Feb 2, 2017	EXHIBIT	PETITIONER
Curriculum Vitae of Dr. Maureen Donovan	Feb 2, 2017	EXHIBIT	PETITIONER
Avicel RC-591	Feb 2, 2017	EXHIBIT	PETITIONER
Declaration of Dr. Robert Schleimer	Feb 2, 2017	EXHIBIT	PETITIONER
Declaration of Dr. Maureen Donovan	Feb 2, 2017	EXHIBIT	PETITIONER
Petition	Feb 2, 2017	PAPER	PETITIONER